TotalMarketCap

Celldex Therapeutics

CLDXNasdaq United StatesHealth CareBiotechnology: In Vitro & In Vivo Diagnostic Substances

Market cap

$2.224 B

$28.32 -5.38%

Close of 6 Nov 2026

As of 6 Nov 2026, Celldex Therapeutics (CLDX) has a market capitalization of $2.22B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$1.54M

#3420 by revenue

Earnings

-$258.8M

Loss-making

Shares outstanding

78,545,051

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: In Vitro & In Vivo Diagnostic Substances, ranked by market cap

All 19 →
  1. #3Oruka TherapeuticsORKA$6.36B
  2. #4NeogenNEOG$2.54B
  3. #5Celldex TherapeuticsCLDX$2.22B
  4. #6Intellia TherapeuticsNTLA$1.56B
  5. #7QuidelOrthoQDEL$886.3M

What if Celldex Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$359,570.13

Per share 12,697× higher

Bitcoin $1.53T

$19,455.71

Per share 687× higher

Apple $5.02T

$63,871.29

Per share 2,255× higher

Or at a round number

$5.00B$10.0B$20.0B$50.0B

Where these numbers come from

Share counts and financials for Celldex Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.